2021
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
India
|
|
|
USA
|
|
|
UK
|
|
|
China
|
Detailed explanation-1: -Molnupiravir was developed at Emory University by its drug innovation company, Drug Innovation Ventures at Emory (DRIVE).
Detailed explanation-2: -The vaccine is administered in two doses that are given three weeks apart. In December 2020, the UK became the first country in the world to approve this vaccine and began rolling out an initial 800, 000 doses at the start of the month, and is now in use worldwide.
Detailed explanation-3: -Molnupiravir received its first approval on 4 November 2021 in the UK for the treatment of mild to moderate COVID-19 in adults with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic test and who have at least one risk factor for developing severe illness.
Detailed explanation-4: -Approved Drugs Olumiant (baricitinib) is approved for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).